Alnylam Pharma (ALNY.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Nov23

Vanguard Group Increased Position in Aurinia Pharmaceuticals

08:15

Nov19

Kevin Fitzgerald Disposes of Almirall Ordinary Shares

21:06

Nov11

Wells Fargo Raises Arlamm Pharmaceuticals' Target Price

20:06

Oct31

Jennison Associates LLC Increases Holdings in Alnylam Pharmaceuticals

09:23

Oct30

Alnylam Pharma released FY2025 Q3 earnings on October 30 Pre-Market EST, actual revenue USD 1.249 B (forecast USD 974.12 M), actual EPS USD 1.84 (forecast USD 0.5474)

13:30

Alnylam Pharma released FY2025 9 Months Earnings on October 30 Pre-Market EST, Actual Revenue USD 2.617 B, Actual EPS USD 0.8893

13:30

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.249 B, Net Income 251.08 M, EPS 1.84

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 773.69 M, Net Income -66.28 M, EPS -0.5073

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 594.19 M, Net Income -57.48 M, EPS -0.4432

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change